BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 32623334)

  • 21. Geraniol Protects Against the Protein and Oxidative Stress Induced by Rotenone in an In Vitro Model of Parkinson's Disease.
    Rekha KR; Inmozhi Sivakamasundari R
    Neurochem Res; 2018 Oct; 43(10):1947-1962. PubMed ID: 30141137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased serum hepcidin concentration correlates with brain iron deposition in patients with HBV-related cirrhosis.
    Lin D; Ding J; Liu JY; He YF; Dai Z; Chen CZ; Cheng WZ; Zhou J; Wang X
    PLoS One; 2013; 8(6):e65551. PubMed ID: 23776499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine, Alpha-Synuclein, and Mitochondrial Dysfunctions in Parkinsonian Eyes.
    Indrieri A; Pizzarelli R; Franco B; De Leonibus E
    Front Neurosci; 2020; 14():567129. PubMed ID: 33192254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroprotection of Rotenone-Induced Parkinsonism by Ursolic Acid in PD Mouse Model.
    Zahra W; Rai SN; Birla H; Singh SS; Rathore AS; Dilnashin H; Singh R; Keswani C; Singh RK; Singh SP
    CNS Neurol Disord Drug Targets; 2020; 19(7):527-540. PubMed ID: 32787765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA).
    Ho PW; Leung CT; Liu H; Pang SY; Lam CS; Xian J; Li L; Kung MH; Ramsden DB; Ho SL
    Autophagy; 2020 Feb; 16(2):347-370. PubMed ID: 30983487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells.
    Urrutia P; Aguirre P; Esparza A; Tapia V; Mena NP; Arredondo M; González-Billault C; Núñez MT
    J Neurochem; 2013 Aug; 126(4):541-9. PubMed ID: 23506423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acteoside exerts neuroprotection effects in the model of Parkinson's disease via inducing autophagy: Network pharmacology and experimental study.
    Aimaiti M; Wumaier A; Aisa Y; Zhang Y; Xirepu X; Aibaidula Y; Lei X; Chen Q; Feng X; Mi N
    Eur J Pharmacol; 2021 Jul; 903():174136. PubMed ID: 33940032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Piperine promotes autophagy flux by P2RX4 activation in
    Li R; Lu Y; Zhang Q; Liu W; Yang R; Jiao J; Liu J; Gao G; Yang H
    Autophagy; 2022 Mar; 18(3):559-575. PubMed ID: 34092198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 4E-BP1 Protects Neurons from Misfolded Protein Stress and Parkinson's Disease Toxicity by Inducing the Mitochondrial Unfolded Protein Response.
    Dastidar SG; Pham MT; Mitchell MB; Yeom SG; Jordan S; Chang A; Sopher BL; La Spada AR
    J Neurosci; 2020 Nov; 40(45):8734-8745. PubMed ID: 33046555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolongifolene mitigates rotenone-induced dopamine depletion and motor deficits through anti-oxidative and anti-apoptotic effects in a rat model of Parkinson's disease.
    Balakrishnan R; Vijayraja D; Mohankumar T; Manimaran D; Ganesan P; Choi DK; Elangovan N
    J Chem Neuroanat; 2021 Mar; 112():101890. PubMed ID: 33220427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TFEB regulates cellular labile iron and prevents ferroptosis in a TfR1-dependent manner.
    Chen L; Ma Y; Ma X; Liu L; Jv X; Li A; Shen Q; Jia W; Qu L; Shi L; Xie J
    Free Radic Biol Med; 2023 Nov; 208():445-457. PubMed ID: 37683766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.
    Dodiya HB; Forsyth CB; Voigt RM; Engen PA; Patel J; Shaikh M; Green SJ; Naqib A; Roy A; Kordower JH; Pahan K; Shannon KM; Keshavarzian A
    Neurobiol Dis; 2020 Feb; 135():104352. PubMed ID: 30579705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myricetin reduces cytotoxicity by suppressing hepcidin expression in MES23.5 cells.
    Deng H; Liu S; Pan D; Jia Y; Ma ZG
    Neural Regen Res; 2021 Jun; 16(6):1105-1110. PubMed ID: 33269757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutant A53T alpha-synuclein induces neuronal death by increasing mitochondrial autophagy.
    Choubey V; Safiulina D; Vaarmann A; Cagalinec M; Wareski P; Kuum M; Zharkovsky A; Kaasik A
    J Biol Chem; 2011 Mar; 286(12):10814-24. PubMed ID: 21252228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Artemisia Leaf Extract protects against neuron toxicity by TRPML1 activation and promoting autophagy/mitophagy clearance in both in vitro and in vivo models of MPP+/MPTP-induced Parkinson's disease.
    Wu LK; Agarwal S; Kuo CH; Kung YL; Day CH; Lin PY; Lin SZ; Hsieh DJ; Huang CY; Chiang CY
    Phytomedicine; 2022 Sep; 104():154250. PubMed ID: 35752074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SIRT3 Acts as a Neuroprotective Agent in Rotenone-Induced Parkinson Cell Model.
    Zhang JY; Deng YN; Zhang M; Su H; Qu QM
    Neurochem Res; 2016 Jul; 41(7):1761-73. PubMed ID: 27053302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of Prolyl Oligopeptidase Restores Spontaneous Motor Behavior in the α-Synuclein Virus Vector-Based Parkinson's Disease Mouse Model by Decreasing α-Synuclein Oligomeric Species in Mouse Brain.
    Svarcbahs R; Julku UH; Myöhänen TT
    J Neurosci; 2016 Dec; 36(49):12485-12497. PubMed ID: 27927963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-1beta mediates sleep alteration in rats with rotenone-induced parkinsonism.
    Yi PL; Tsai CH; Lu MK; Liu HJ; Chen YC; Chang FC
    Sleep; 2007 Apr; 30(4):413-25. PubMed ID: 17520785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. α-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism.
    Yun SP; Kim D; Kim S; Kim S; Karuppagounder SS; Kwon SH; Lee S; Kam TI; Lee S; Ham S; Park JH; Dawson VL; Dawson TM; Lee Y; Ko HS
    Mol Neurodegener; 2018 Jan; 13(1):1. PubMed ID: 29310663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Overview on the Role of α -Synuclein in Experimental Models of Parkinson's Disease from Pathogenesis to Therapeutics.
    Javed H; Kamal MA; Ojha S
    CNS Neurol Disord Drug Targets; 2016; 15(10):1240-1252. PubMed ID: 27658511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.